2026-04-23T13:01:07Z https://www.peertechzpublications.org/oai-pmh

oai:www.peertechzpublications.org:10.17352/ojor.000055 2025-12-18 PTZ.OJOR:VOL10

Predicting Physiotherapy Management of Musculoskeletal Abnormalities by 2030—A Phase-Specific Evidence-Based Protocol Integrating DNA-Level Prognostic Insights P Muthkrishnan<p>The forecasting model underpinning future adoption of phase-specific, DNA-informed physiotherapy protocols employs a hybrid methodological framework, integrating population-level epidemiological data, genomic biobank insights, and contemporary clinical adoption trends. Key assumptions include:</p><p>- The routine clinical utility of DNA-based prognostic profiling for musculoskeletal disorders by 2030, facilitated by declining costs and expanded biorepository access.</p><p>- Accelerated adoption of digital health and AI-powered rehabilitation technologies, following a sigmoidal (logistic) growth curve, sensitive to sociodemographic and policy variables.</p><p>- Stratified patient management anchored both in genomic risk and longitudinal function, enabling precision technology deployment and tailored rehabilitation intensity.</p> Open Journal of Orthopedics and Rheumatology - Peertechz Publications 2025-12-18 Research Article https://doi.org/10.17352/ojor.000055 en Copyright © P Muthkrishnan et al.